Romania's Antibiotice Iași cuts electricity bill by 20% with own solar park

18 August 2026 Romanian state-controlled pharmaceutical producer Antibiotice Iași (BVB: ATB) reduced its electricity expenses by 20% in the first half of 2026 compared with the same period last year, following the use of its own photovoltaic generation, according to the company's H1 financial report submitted to the Bucharest Stock Exchange and cited by Economedia.ro. The company said its combined expenses for electricity, natural gas and drinking water fell to RON 11.68 million in the first six months of 2026, from RON 12.52 million a year earlier. Electricity costs accounted for most of the reduction in utility expenses. The photovoltaic plants generated savings of approximately 20% of the electricity consumed during the period, equivalent to RON 1.2 million based on the average purchase